The Latest SPAC News and Rumors: June 25, 2021
by Marlena Haddad on 2021-06-25 at 11:40am

Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. 

Latest SPAC News: Churchill Capital IV is set to vote on merger with Lucid Motors, dozens of SPAC deals to enter Russell 3000 index, Jim Chanos warns of SPAC market, and Credit Suisse’s deals dry up 

 


Churchill Capital IV Announces Shareholder Vote Date For Lucid Motors Merger

Churchill Capital IV is set to vote on its merger with Lucid Motors on July 22, and a redemption deadline of July 20.

READ

Dozens of Groups Brought to Market Via SPACs to Enter Key Russell Index

Dozens of companies that entered US markets through deals with SPACs in the past year are set to graduate into the Russell 3000 index on Friday evening, giving a potential boost to the fortunes of electric vehicle (EV) developers and other speculative ventures, according to the Financial Times.

Among those companies are Canoo, Lordstown Motors and Nikola, companies that have dealt with the departures of key personnel and face investigations from the SEC over their disclosures to investors. All three have said they are cooperating with regulators.

Other notable additions will include the sports betting business DraftKings, healthcare company Multiplan and 3D sensors manufacturer Velodyne Lidar, according to Russell’s preliminary list.

READ

SPAC Boom Is Creating “Castles In The Sky”, Jim Chanos Warns

Jim Chanos, who is the founder of Kynikos Associates and best-known for predicting the collapse of energy group Enron, accused some who have taken companies public via a SPAC of “playing fast and loose with their projections” in an effort to attract retail investors.

Kynikos Associates is betting against a number of blank check companies that are “very bad businesses” and whose valuations “have gotten silly”, Chanos said. He declined to name them.

However, Kynikos is not entirely opposed to the SPAC market as it has taken long positions in blank check vehicles that are trading below $10.

READ

Credit Suisse’s SPAC Bonanza Dries Up

Credit Suisse’s SPAC deals are being closely monitored by investors and analysts, because revenue from them came to represent a large chunk of overall investment banking revenue last year. That raised concerns that the fees and deal volume might not be sustainable.

Credit Suisse went from making an estimated $466 million in gross SPAC underwriting fees in the first quarter, to $16.1 million between April 1 and June 15, according to the Wall Street Journal.

READ

 

Recent Posts
by Nicholas Alan Clayton on 2024-07-24 at 4:38pm

Launch Two (NASDAQ:LPBBU) has filed for a $200 million IPO that shows how the market has shifted for new issuance since its sister SPAC Launch One (NASDAQ:LPAAU) filed just over a month ago. Both SPACs are underwritten by Cantor Fitzgerald and seeking nominally the same raise at IPO, but Launch Two is overfunding its trust...

by Nicholas Alan Clayton on 2024-07-24 at 1:19pm

FTAC Emerald (NASDAQ:EMLD) has entered into a definitive agreement to combine with crypto fintech firm Fold at an enterprise value of $381 million. Phoenix, Arizona-based Fold provides digital banking services backed by a treasury of Bitcoin that includes FDIC-secured checking accounts as well Bitcoin trading and awards. The combined company is expected to trade on...

by Nicholas Alan Clayton on 2024-07-24 at 8:19am

At the SPAC of Dawn Dealmakers remain confident that AI is going to play a big role in their M&A processes, but feel unprepared for some the changes, according to a new survey of 225 corporate and 75 private equity transactions professionals. SS&C subsidiary Mergermarket generated the report that found more than half of respondents...

by Nicholas Alan Clayton on 2024-07-23 at 4:33pm

Trailblazer Merger I (NASDAQ:TBMC) has entered into a definitive agreement to combine with data intelligence firm Cyabra at an enterprise value of $70 million. Tel Aviv-based Cyabra provides tools to corporations and governments to identify fake accounts and combat social media disinformation. The combined company is expected to trade on the Nasdaq once the deal...

by Nicholas Alan Clayton on 2024-07-23 at 1:00pm

Chain Bridge I (NASDAQ:CBRG) has entered into a definitive agreement to combine with cannabinoid pharmaceuticals firm Phytanix Bio at a pre-deal valuation of $58 million. Santa Barbara, California-based Phytanix is working to develop bladder and seizure treatments using cannabis-based substances. The combined company is expected to trade on the Nasdaq under the symbol “PHYX” once...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved